Daily Newsletter

01 December 2023

Daily Newsletter

01 December 2023

Memphis Vascular Center launches new outpatient centre in US

Specialising in vascular and interventional radiology, the centre features advanced imaging equipment and treatment rooms.

December 01 2023

Memphis Vascular Center (MVC) has launched a new outpatient diagnostic and treatment facility in Memphis, Tennessee, US, to provide care for vascular disease, cancer, and various health conditions.

Specialising in vascular and interventional radiology, MVC's team of interventional radiologists uses advanced diagnostic imaging equipment to perform minimally invasive treatments.

The outpatient centre addresses a range of conditions, including peripheral arterial disease, varicose veins, liver cancer, uterine fibroids, enlarged prostate, knee pain from osteoarthritis, chronic bleeding haemorrhoids, and spinal compression fractures.

MVC medical director and interventional radiologist Scott Osborne said: “Interventional radiology is rapidly becoming the standard of care for treating certain health issues that once required surgery.

“Thanks to our new centre, patients can be treated in an outpatient setting, where convenience and exceptional care are the priority.

“Other benefits include a lower risk of hospital-acquired infections and lower overall cost.”

All procedures offered are said to be FDA-cleared, virtually pain-free, and will allow patients to return home the same day as their treatment, resuming normal activities shortly.

This approach is claimed to offer a viable and cost-effective alternative to traditional open surgery.

“The solutions that we offer are some of the most highly advanced medical procedures available today," Osborne added.

“Each year, hundreds of thousands of women undergo hysterectomy or myomectomy to treat their fibroids. However, surgically removing fibroids from the uterus, or removing the uterus itself, is no longer required to treat this condition."

“With interventional radiology, we block or ‘embolise’ the blood vessels that feed the fibroid. Without a blood supply, the fibroids shrink, and symptoms disappear.

“No open surgery required, no scarring, very little recovery time and lasting results.”

The aging population is a captive market for medical devices

The rising number of older individuals globally is accompanied by increasing health concerns, presenting unique demand for the medical device industry. With rising pressure on governments, payers, and manufacturers to reduce healthcare costs, innovative medical technologies have tremendous potential to improve elder care. Advancements in medical device technology have resulted in a significant increase in the number of conditions that can be managed in a home care setting. To capitalize on this strong demand and growth, manufacturers are increasingly producing consumer-targeted equipment.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close